Pharma Mar | PHM - Ebitda

Stock Price
96.30
Daily Change
-1.30 -1.33%
Monthly
-1.23%
Yearly
22.68%
Q2 Forecast
96.97

Pharma Mar reported EUR2.71M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Almirall EUR 114.07M 60.37M Dec/2025
Avita Medical AUD -9.69M 12.21M Dec/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Ionis Pharmaceuticals USD -200.02M 42.89M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Moderna USD -790M 582M Dec/2025
Organon & Co USD 415M 32M Mar/2026
Pharma Mar EUR 2.71M 42.25M Mar/2026
Revvity USD 272.91M 24M Mar/2026
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Viatris USD 1.05B 46.4M Mar/2026
Xeris Pharmaceuticals USD 25.09M 7.67M Dec/2025